Intrapartum Monitoring Devices Market Report 2024

This Intrapartum Monitoring Devices market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The intrapartum monitoring devices market size has grown strongly in recent years. It will grow from $2.04 billion in 2023 to $2.18 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period can be attributed to technological advancements, increasing maternal age, a higher prevalence of preterm births, government initiatives and funding, as well as growing awareness and education.

The intrapartum monitoring devices market size is expected to see strong growth in the next few years. It will grow to $2.85 billion in 2028 at a compound annual growth rate (CAGR) of 7%. The anticipated growth during the forecast period can be attributed to the increasing incidence of pregnancy complications, heightened awareness and education, government initiatives and policies, rising healthcare expenditure, and an aging maternal population. Key trends expected during this period include the adoption of wireless monitoring devices, integration of telehealth, a growing prevalence of high-risk pregnancies, enhanced accuracy and reliability, and updates in regulatory approvals and guidelines.

The increasing prevalence of gynecological diabetes is expected to drive the growth of the intrapartum monitoring device market in the future. Gynecological diabetes, or gestational diabetes mellitus (GDM), is a condition marked by elevated blood sugar levels that develop during pregnancy and usually resolve after childbirth. The rise in gynecological diabetes is attributed to growing rates of obesity and sedentary lifestyles. Intrapartum monitoring devices are utilized in cases of gynecological diabetes to continuously track fetal heart rate and uterine contractions, ensuring timely detection and management of potential complications during labor and delivery. For example, in 2022, the International Diabetes Federation, a Belgium-based organization, reported that in 2021, approximately 21.1 million live births, or 16.7%, involved some degree of high blood glucose (hyperglycemia) during pregnancy. This condition is particularly prevalent in low- and middle-income countries with limited access to maternal care. Women over 45 and those with a history of GDM are at higher risk of hyperglycemia during pregnancy and are more likely to develop type 2 diabetes within five to ten years post-delivery. Consequently, the rising prevalence of gynecological diabetes is fueling the growth of the intrapartum monitoring device market.

Leading companies in the intrapartum monitoring device market are focusing on developing innovative products, such as wireless and belt-free designs, to maintain their market position. These designs enable unobstructed movement and increased comfort for the mother while ensuring continuous monitoring of fetal heart rate and uterine contractions. For example, in February 2024, GE HealthCare Technologies Inc., a US-based medical technology company, received clearance for its Novii+ Wireless Maternal and Fetal Monitoring Solution. This approval allows the device to monitor approximately 95% of all eligible births in the United States. The Novii+ system is designed for use with pregnant patients at or beyond 34 weeks and provides noninvasive monitoring of fetal heart rate, maternal heart rate, and uterine activity. Its wireless and belt-free design enhances mobility and aims to improve the comfort and experience of expectant mothers during labor. The device also features an advanced algorithm known as cross-check artifact reduction, which enhances the accuracy and reliability of the data collected.

In March 2021, The Cooper Companies Inc., a US-based medical device firm, acquired Safe Obstetric Systems for an undisclosed sum. This acquisition enables Cooper Companies to broaden its impact in the obstetric market, enhance its product lineup, and improve healthcare outcomes for women and infants. Safe Obstetric Systems, a UK-based medical device company, specializes in manufacturing devices for obstetric care, including intrapartum monitoring devices.

Major companies operating in the intrapartum monitoring devices market are Cardinal Health Inc, Medtronic PLC, Fujifilm Holdings Corporation, Philips Healthcare, GE HealthCare Technologies Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd, Drägerwerk AG & Co. KGaA, CooperSurgical Inc., Spacelabs Healthcare, Nihon Kohden Corporation, Contec Medical Systems Co Ltd., Mediana Co Ltd., Natus Medical Incorporated, EDAN Instruments Inc., Guangdong Biolight Meditech Co. Ltd, Dixion Vertrieb medizinischer Geräte GmbH, Bionet America Inc., Shenzhen Bestman Instrument Co Ltd., Huntleigh Healthcare Limited, Neoventa Medical AB, Trismed Co Ltd.

North America was the largest region in the intrapartum monitoring devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intrapartum monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intrapartum monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Intrapartum monitoring devices are specialized medical instruments designed to continuously track the health of both the mother and fetus during labor and delivery. These tools ensure the safety of both mother and baby by providing real-time data that assists healthcare providers in making informed decisions.

The primary types of intrapartum monitoring devices are monitors and electrodes. Monitors are devices used during labor and delivery to continuously track the fetal heart rate and uterine contractions. These devices can employ either invasive or non-invasive methods and are utilized by various end users, including hospitals, maternity centers, and others.

The intrapartum monitoring devices market research report is one of a series of new reports that provides intrapartum monitoring devices market statistics, including intrapartum monitoring devices industry global market size, regional shares, competitors with an intrapartum monitoring devices market share, detailed intrapartum monitoring devices market segments, market trends, and opportunities, and any further data you may need to thrive in the intrapartum monitoring devices industry. This intrapartum monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intrapartum monitoring devices market consists of sales of electronic fetal monitors (EFMs), tocodynamometers, doppler ultrasound devices, and telemetry systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.